Avricore Health Inc - Asset Resilience Ratio

Latest as of September 2025: 0.75%

Avricore Health Inc (AVCR) has an Asset Resilience Ratio of 0.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$10.00K

≈ $7.23K USD Cash + Short-term Investments

Total Assets

CA$1.33 Million

≈ $961.59K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Avricore Health Inc's Asset Resilience Ratio has changed over time. Check Avricore Health Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Avricore Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Avricore Health Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$10.00K	0.75%
Total Liquid Assets	CA$10.00K	0.75%

Asset Resilience Insights

Limited Liquidity: Avricore Health Inc maintains only 0.75% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Avricore Health Inc Industry Peers by Asset Resilience Ratio

Compare Avricore Health Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%

Annual Asset Resilience Ratio for Avricore Health Inc (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Avricore Health Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.44%	CA$10.00K ≈ $7.23K	CA$2.30 Million ≈ $1.66 Million	+0.04pp
2023-12-31	0.39%	CA$10.00K ≈ $7.23K	CA$2.54 Million ≈ $1.84 Million	+0.00pp
2022-12-31	0.39%	CA$10.00K ≈ $7.23K	CA$2.57 Million ≈ $1.86 Million	-13.20pp
2021-12-31	13.59%	CA$310.00K ≈ $224.25K	CA$2.28 Million ≈ $1.65 Million	-75.35pp
2008-12-31	88.94%	CA$1.58 Million ≈ $1.15 Million	CA$1.78 Million ≈ $1.29 Million	--

pp = percentage points

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research

Market Cap

$4.03 Million

CA$5.57 Million CAD

Market Cap Rank

#28938 Global

#1315 in Canada

Share Price

CA$0.06

Change (1 day)

+10.00%

52-Week Range

CA$0.05 - CA$0.09

All Time High

CA$8.32